Aarey Drugs Board Meeting for Q2 FY27 Results

Aarey Drugs & Pharmaceuticals Limited has intimated the stock exchanges about a scheduled meeting of its Board of Directors.

The Board meeting is scheduled to be held on Saturday, 14th November 2026.

The primary agenda for the meeting is:

1. To consider and approve the Unaudited Financial Results along with the Limited Review Report for the quarter and half year ended 30th September 2026.

Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the company's trading window has been closed for insiders. The closure period is from 1st October 2026 and will remain closed until 48 hours after the announcement/declaration of the Unaudited Financial Results.

The communication was digitally signed by Nimit Ghatalia, Director (DIN: 07069841), on behalf of the company.